ArticleEuropean thyroid journal2026

Improved adequacy of levothyroxine treatment in low-risk differentiated thyroid cancer using the 2025 ATA criteria: a multicenter real-world analysis of 1,016 patients.

Juan J Díez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.